Cytokines and chemokines in plasma as markers reflecting immunophenotype of head and neck squamous cell carcinoma
Human Cell · 2026
DOI: 10.1007/s13577-026-01436-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, 2026. Verfasst von Susumu Suzuki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Creation Support Center, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, 480-1195, Japan. suzukis@aichi-med-u.ac.jp. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Immunophenotyping, Cytokines, Biomarkers, Tumor. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Ministry of Education.
Abstract (Originalsprache)
Cancer immunophenotypes—immune desert (ID), immune excluded (IE), and immune inflamed (II)—reflect intratumoral immune activity and correlate with immunotherapy efficacy. Serological methods for non-invasive immunophenotyping would be clinically valuable for selecting therapies. We measured plasma concentrations of cytokines (IL-6, IL-10, IL-16, IL-18, VEGF), chemokines (CXCL9, CXCL13), and soluble membrane molecules (sPD-1, sPD-L1, sCTLA-4, sCD163) in 49 patients with head and neck squamous cell carcinoma (HNSCC) and 22 healthy donors using an automated chemiluminescence enzyme immunoassay system. Plasma levels of IL-6, IL-10, VEGF, CXCL9, CXCL13, and sCD163 were significantly higher in patients with HNSCC than in healthy donors. IL-10 levels trended higher in the order ID > IE > II, whereas CXCL9, CXCL13, and sCD163 levels trended higher in the order II > IE > ID. This progressive trend across phenotypes was further enhanced by calculating the ratios of these markers to IL-10. Significantly higher sPD-1 levels were observed in the II phenotype. These results indicate that plasma concentrations and ratios of CXCL9, CXCL13, sCD163, IL-10, and sPD-1 serve as potential surrogate biomarkers reflecting tumor immunophenotypes in HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Creation Support Center, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, 480-1195, Japan. suzukis@aichi-med-u.ac.jp.
- Department of Pathology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, 480-1195, Japan.
- Research Creation Support Center, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, 480-1195, Japan.
- Central Research Laboratories, Sysmex Corporation, 4-4-4 Takatsukadai, Nishi-ku, Kobe, 651-2271, Japan.
- Sysmex R&D Center Europe GmbH, Falkenried 88, 20251, Hamburg, Germany.
- Department of Otorhinolaryngology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, 480-1195, Japan.
Förderung
- Ministry of Education
Zitieren
APA
Suzuki, S., Ito, H., Okubo, I., Uga, H., Iwanaga, N., Hasegawa, T., Nakamura, H., Inukai, D., Sano, R., Takahara, T., Tsuzuki, T., & Ogawa, T. (2026). Cytokines and chemokines in plasma as markers reflecting immunophenotype of head and neck squamous cell carcinoma. Human Cell. https://doi.org/10.1007/s13577-026-01436-7
Vancouver
Suzuki S, Ito H, Okubo I, Uga H, Iwanaga N, Hasegawa T, et al. Cytokines and chemokines in plasma as markers reflecting immunophenotype of head and neck squamous cell carcinoma. Human Cell. 2026. doi:10.1007/s13577-026-01436-7
BibTeX
@article{Suzuki2026,
author = {Suzuki, Susumu and Ito, Hideaki and Okubo, Ikuko and Uga, Hitoshi and Iwanaga, Niina and Hasegawa, Takehiro and Nakamura, Hiromu and Inukai, Daisuke and Sano, Rui and Takahara, Taishi and Tsuzuki, Toyonori and Ogawa, Tetsuya},
title = {Cytokines and chemokines in plasma as markers reflecting immunophenotype of head and neck squamous cell carcinoma},
journal = {Human Cell},
year = {2026},
doi = {10.1007/s13577-026-01436-7}
}
EUVIMED